Risks of TDF Medications for HIV Patients

Risks of TDF Medications for HIV Patients

There are five Gilead TDF drugs available to people infected with HIV: Viread, Truvada, Atripla, Complera, and Stribild. It has been alleged that Gilead both failed to warn doctors and patients of the increased risks and toxicity of their HIV medications and withheld a safer alternative from the market called TAF (tenofovir alafenamide fumarate). This resulted in victims not being able to make informed decisions about their health that could have helped them avoid these injuries.

TDF side effects:

  • Bone mineral density loss / bone density loss, Bone injuries, Bone fractures,
  • Lactic acidosis,
  • Osteopenia – osteoporosis’s precursor where bone density is below peak level as signaled by shorter height, stooped over posture, back pain, and bone demineralization,
  • Osteoporosis – where old bone tissue dies, and new tissue stops growing or grows too slowly to replace it, which may result in fractures from small movements or falls,
  • Acute kidney injury (AKI) – where waste is not filtered well from blood,
  • Kidney damage and kidney problems, reduced kidney function,
  • acute renal failure (ARF) / kidney failure,
  • Renal tubular acidosis – a renal condition where the blood contains increased acid that the kidneys fail to filter out,
  • Fanconi Syndrome – a tubule disorder where the urine contains increased levels of glucose, potassium, and bicarbonate,
  • chronic kidney disease – a disorder where waste may build up to dangerous levels,

There have not yet been any settlements with drug manufacturer Gilead in Truvada cases or TDF lawsuits. The Truvada lawsuit payout is likely to be substantial because of the profits that TDF drugs have made Gilead Sciences, Inc. and the potential for punitive damages being assessed against the company.

Settlements of TDF lawsuits aim to compensate TDF victims for their losses, including:

  • Past medical bills,
  • Future medical expenses associated with side effects of TDF or Truvada,
  • Lost wages and reduced earning capacity,
  • Pain and suffering, and
  • The loss of companionship suffered by the victim’s family.

The Gilead lawsuits allege that this course of conduct allowed the company to reap around $18 billion per year on its HIV drugs, all while putting patients at risk. There are likely thousands of people who have suffered from the serious side effects of Truvada or other TDF drugs.

If you were diagnosed by a physician or other healthcare provider with kidney issues or experienced bone density loss after starting a TDF Drug (Viread, Truvada, Atripla, Complera or Stribild) or have been exacerbated after starting the TDF drug, you may be eligible for compensation. Forester Haynie is currently pursuing clients’ claims against this drug manufacturer. Contact us today at 214-210-2100 or info@foresterhaynie.com to learn more about this litigation and holding Gilead accountable.

Contact Us Today

Leave a Reply

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.